Wave Life Sciences (WVE) Cash & Current Investments (2014 - 2026)
Wave Life Sciences posted quarterly Cash & Current Investments of $544.6 million for Q1 2026, up 124.02% year-on-year from $243.1 million in Q1 2025, and down 9.55% on a QoQ basis from $602.1 million in Q4 2025.
Wave Life Sciences (WVE) has 13 years of Cash & Current Investments data on file, last reported at $544.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 124.02% year-over-year to $544.6 million; the trailing twelve-month figure through Mar 2026 stood at $544.6 million (up 124.02% YoY), and the FY2025 full-year result was $602.1 million, up 99.31% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $544.6 million, down from $602.1 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $602.1 million in Q4 2025 and bottomed at $88.5 million in Q4 2022.
- The 5-year median for Cash & Current Investments is $196.2 million (2025), against an average of $232.9 million.
- The widest annual swing landed in 2022, when Cash & Current Investments slumped 41.22%; it then soared 126.39% in 2023.
- A 5-year view of Cash & Current Investments shows it stood at $88.5 million in 2022, then soared by 126.39% to $200.4 million in 2023, then jumped by 50.77% to $302.1 million in 2024, then surged by 99.31% to $602.1 million in 2025, then fell by 9.55% to $544.6 million in 2026.
- The last three Cash & Current Investments figures came in at $544.6 million (Q1 2026), $602.1 million (Q4 2025), and $196.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 544.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 544.60 Mn |
| Dec 31, 2025 | 602.07 Mn |
| Sep 30, 2025 | 196.20 Mn |
| Jun 30, 2025 | 208.48 Mn |
| Mar 31, 2025 | 243.10 Mn |
| Dec 31, 2024 | 302.08 Mn |
| Sep 30, 2024 | 310.90 Mn |
| Jun 30, 2024 | 154.00 Mn |
| Mar 31, 2024 | 180.90 Mn |
| Dec 31, 2023 | 200.35 Mn |
| Sep 30, 2023 | 139.90 Mn |
| Jun 30, 2023 | 173.00 Mn |
| Mar 31, 2023 | 207.56 Mn |
| Dec 31, 2022 | 88.50 Mn |
| Sep 30, 2022 | 147.04 Mn |
| Jun 30, 2022 | 148.16 Mn |
| Mar 31, 2022 | 111.71 Mn |
| Dec 31, 2021 | 150.56 Mn |
| Sep 30, 2021 | 123.90 Mn |
| Jun 30, 2021 | 143.80 Mn |
| Mar 31, 2021 | 148.54 Mn |
| Dec 31, 2020 | 184.50 Mn |
| Sep 30, 2020 | 216.36 Mn |
| Jun 30, 2020 | 216.40 Mn |
| Mar 31, 2020 | 120.90 Mn |
| Dec 31, 2019 | 147.16 Mn |
| Sep 30, 2019 | 209.01 Mn |
| Jun 30, 2019 | 252.91 Mn |
| Mar 31, 2019 | 287.57 Mn |
| Dec 31, 2018 | 174.82 Mn |
| Sep 30, 2018 | 210.49 Mn |
| Jun 30, 2018 | 241.43 Mn |
| Mar 31, 2018 | 110.49 Mn |
| Dec 31, 2017 | 142.50 Mn |
| Sep 30, 2017 | 168.46 Mn |
| Jun 30, 2017 | 197.39 Mn |
| Mar 31, 2017 | 129.48 Mn |
| Dec 31, 2016 | 150.29 Mn |
| Sep 30, 2016 | 169.02 Mn |
| Jun 30, 2016 | 181.77 Mn |
| Mar 31, 2016 | 153.40 Mn |
| Dec 31, 2015 | 161.22 Mn |
| Sep 30, 2015 | 66.04 Mn |
| Jun 30, 2015 | 7.78 Mn |
| Mar 31, 2015 | 10.96 Mn |
| Dec 31, 2014 | 1.05 Mn |
| Sep 30, 2014 | 2.49 Mn |